Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
International Journal of Molecular Sciences
|
December 11, 2022
Redefining Hypo- and Hyper-Responding Phenotypes of CFTR Mutants for Understanding and Therapy
Tamara Hillenaar, Jeffrey Beekman, Peter van der Sluijs, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
March 25, 2026
Reply: Lung organoids: a new frontier in neonatology and paediatric respiratory medicine
Lorenzo Zanetto, Luca Bonadies, Raquel Moll-Diaz, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
August 6, 2025
Lung organoids: a new frontier in neonatology and paediatric respiratory medicine
Lorenzo Zanetto, Luca Bonadies, Raquel Moll-Diaz, et al.
Bioconjugate Chemistry
|
January 11, 2019
Strong Inhibition of Cholera Toxin B Subunit by Affordable, Polymer-Based Multivalent Inhibitors
Diksha Haksar, Eyleen de Poel, Linda Quarles van Ufford, et al.
The Journal of Allergy and Clinical Immunology
|
August 1, 2013
Der p 1-induced CD4⁺FOXP3⁺GATA3⁺ T cells have suppressive properties and contribute to the polarization of the TH2-associated response
Lieke Reubsaet, Jenny Meerding, Rianne Giezeman, et al.
The European Respiratory Journal
|
October 19, 2023
Organoid-guided synergistic treatment of minimal function CFTR mutations with CFTR modulators, roflumilast and simvastatin: a personalised approach
Sacha Spelier, Karin de Winter-de Groot, Natascha Keijzer-Nieuwenhuijze, et al.
Cell
|
August 23, 2024
In vitro human cell-based models: What can they do and what are their limitations?
Matthias P Lutolf, Milica Radisic, Jeffrey Beekman, et al.
Trends in Biotechnology
|
November 3, 2024
In vitro human cell-based models: What can they do and what are their limitations?
Matthias P Lutolf, Milica Radisic, Jeffrey Beekman, et al.
Journal of Personalized Medicine
|
December 24, 2021
Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators
Danya Muilwijk, Marlou Bierlaagh, Peter van Mourik, et al.
Human Mutation
|
November 30, 2018
The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read-through therapies in cystic fibrosis
Luka A Clarke, Nikhil T Awatade, Veronica M Felício, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
International Journal of Molecular Sciences
|
December 11, 2022
Redefining Hypo- and Hyper-Responding Phenotypes of CFTR Mutants for Understanding and Therapy
Tamara Hillenaar, Jeffrey Beekman, Peter van der Sluijs, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
March 25, 2026
Reply: Lung organoids: a new frontier in neonatology and paediatric respiratory medicine
Lorenzo Zanetto, Luca Bonadies, Raquel Moll-Diaz, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
August 6, 2025
Lung organoids: a new frontier in neonatology and paediatric respiratory medicine
Lorenzo Zanetto, Luca Bonadies, Raquel Moll-Diaz, et al.
Bioconjugate Chemistry
|
January 11, 2019
Strong Inhibition of Cholera Toxin B Subunit by Affordable, Polymer-Based Multivalent Inhibitors
Diksha Haksar, Eyleen de Poel, Linda Quarles van Ufford, et al.
The Journal of Allergy and Clinical Immunology
|
August 1, 2013
Der p 1-induced CD4⁺FOXP3⁺GATA3⁺ T cells have suppressive properties and contribute to the polarization of the TH2-associated response
Lieke Reubsaet, Jenny Meerding, Rianne Giezeman, et al.
The European Respiratory Journal
|
October 19, 2023
Organoid-guided synergistic treatment of minimal function CFTR mutations with CFTR modulators, roflumilast and simvastatin: a personalised approach
Sacha Spelier, Karin de Winter-de Groot, Natascha Keijzer-Nieuwenhuijze, et al.
Cell
|
August 23, 2024
In vitro human cell-based models: What can they do and what are their limitations?
Matthias P Lutolf, Milica Radisic, Jeffrey Beekman, et al.
Trends in Biotechnology
|
November 3, 2024
In vitro human cell-based models: What can they do and what are their limitations?
Matthias P Lutolf, Milica Radisic, Jeffrey Beekman, et al.
Journal of Personalized Medicine
|
December 24, 2021
Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators
Danya Muilwijk, Marlou Bierlaagh, Peter van Mourik, et al.
Human Mutation
|
November 30, 2018
The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read-through therapies in cystic fibrosis
Luka A Clarke, Nikhil T Awatade, Veronica M Felício, et al.
Page
of 2